Nasulin intranasal insulin: Phase II started

BNT began an Indian Phase II trial of intranasal Nasulin. BNT granted Biocon rights to develop and market the product in Asia, Africa and the Middle East in 2005 (see BioCentury, Nov. 21, 2005). ...